Curcumin Combined with Thalidomide Reduces Expression of STAT3 and Bcl-xL, Leading to Apoptosis in Acute Myeloid Leukemia Cell Lines

References

• ZhouH-S, CarterBZ, AndreeffM. Bone marrow niche-mediated survival of leukemia stem cells in acute myeloid leukemia: Yin and Yang. Cancer Biol Med. 2016;13(2):248. doi:10.20892/j.issn.2095-3941.2016.002327458532
   PubMed Web of Science ®Google Scholar
• ZahedpanahM, ShaieganM, GhaffariSH, NikbakhtM, NikugoftarM, MohammadiS. Parthenolide induces apoptosis in committed progenitor AML cell line U937 via reduction in osteopontin. Rep Biochem Mol Biol. 2016;4(2):82–88.27536701
   PubMedGoogle Scholar
• RobozGJ, GuzmanM. Acute myeloid leukemia stem cells: seek and destroy. Expert Rev Hematol. 2009;2(6):663–672. doi:10.1586/ehm.09.5321082958
   PubMed Web of Science ®Google Scholar
• WalterRB, AppelbaumFR, TallmanMS, WeissNS, LarsonRA, EsteyEH. Shortcomings in the clinical evaluation of new drugs: acute myeloid leukemia as paradigm. Blood. 2010;116(14):2420–2428. doi:10.1182/blood-2010-05-28538720538802
   PubMed Web of Science ®Google Scholar
• MohammadiS, GhaffariSH, ShaieganM, et al. Acquired expression of osteopontin selectively promotes enrichment of leukemia stem cells through AKT/mTOR/PTEN/β-catenin pathways in AML cells. Life Sci. 2016;152:190–198. doi:10.1016/j.lfs.2016.04.00327063991
   PubMed Web of Science ®Google Scholar
• HaghiA, MohammadiS, HeshmatiM, GhavamzadehA, NikbakhtM. Anti-vascular endothelial growth factor effects of sorafenib and arsenic trioxide in acute myeloid leukemia cell lines. Asian Pac J Cancer Prev. 2017;18:1655–1661. doi:10.22034/APJCP.2017.18.6.165528670885
   PubMedGoogle Scholar
• XiongA, YangZ, ShenY, ZhouJ, ShenQ. Transcription factor STAT3 as a novel molecular target for cancer prevention. Cancers. 2014;6(2):926–957. doi:10.3390/cancers602092624743778
   PubMed Web of Science ®Google Scholar
• DarnellJE. Validating Stat3 in cancer therapy. Nat Med. 2005;11(6):595–596. doi:10.1038/nm0605-59515937466
   PubMed Web of Science ®Google Scholar
• WangT, NiuG, KortylewskiM, et al. Regulation of the innate and adaptive immune responses by Stat-3 signaling in tumor cells. Nat Med. 2004;10(1):48–54. doi:10.1038/nm97614702634
   PubMed Web of Science ®Google Scholar
• TurksonJ, JoveR. STAT proteins: novel molecular targets for cancer drug discovery. Oncogene. 2000;19(56):6613–6626. doi:10.1038/sj.onc.120408611426647
   PubMed Web of Science ®Google Scholar
• TurksonJ. STAT proteins as novel targets for cancer drug discovery. Expert Opin Ther Targets. 2004;8(5):409–422. doi:10.1517/14728222.8.5.40915469392
   PubMed Web of Science ®Google Scholar
• ZhaoJ, XuY, ZongY, et al. Inhibition of Stat3 expression induces apoptosis and suppresses proliferation in human leukemia HL-60 cells. Hematology. 2011;16(4):232–235. doi:10.1179/102453311X1302556894192521756540
   PubMed Web of Science ®Google Scholar
• BenekliM, BaumannH, WetzlerM. Targeting signal transducer and activator of transcription signaling pathway in leukemias. J Clin Oncol. 2009;27(26):4422–4432. doi:10.1200/JCO.2008.21.326419667270
   PubMed Web of Science ®Google Scholar
• Epling-BurnettePK, LiuJH, Catlett-FalconeR, et al. Inhibition of STAT3 signaling leads to apoptosis of leukemic large granular lymphocytes and decreased Mcl-1 expression. J Clin Invest. 2001;107(3):351–362. doi:10.1172/JCI994011160159
   PubMed Web of Science ®Google Scholar
• BiL, YuZ, WuJ, et al. Honokiol inhibits constitutive and inducible STAT3 signaling via PU. 1-induced SHP1 expression in acute myeloid leukemia cells. Tohoku J Exp Med. 2015;237(3):163–172. doi:10.1620/tjem.237.16326466521
   PubMed Web of Science ®Google Scholar
• Catlett-FalconeR, LandowskiTH, OshiroMM, et al. Constitutive activation of Stat3 signaling confers resistance to apoptosis in human U266 myeloma cells. Immunity. 1999;10(1):105–115. doi:10.1016/S1074-7613(00)80011-410023775
   PubMed Web of Science ®Google Scholar
• OltvalZN, MillimanCL, KorsmeyerSJ. Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programed cell death. cell. 1993;74(4):609–619. doi:10.1016/0092-8674(93)90509-O8358790
   PubMed Web of Science ®Google Scholar
• LeeJH, SchütteD, WulfG, et al. Stem-cell protein Piwil2 is widely expressed in tumors and inhibits apoptosis through activation of Stat3/Bcl-XL pathway. Hum Mol Genet. 2006;15(2):201–211. doi:10.1093/hmg/ddi43016377660
   PubMed Web of Science ®Google Scholar
• MohammadiS, ZahedpanahM, NikbakhtM, et al. Parthenolide reduces gene transcription of prosurvival mediators in U937 cells. Exp Oncol. 2017;39(1):30–35. doi:10.31768/2312-8852.2017.39(1):30-3528361855
   PubMedGoogle Scholar
• MohammadiS, GhaffariSH, ShaieganM, et al. Curcumin veto the effects of osteopontin (OPN) specific inhibitor on leukemic stem cell colony forming potential via promotion of OPN overexpression. Int J Hematol Oncol Stem Cell Res. 2016;10(3):120.27489587
   PubMedGoogle Scholar
• JhaAK, NikbakhtM, ParasharG, ShrivastavaA, CapalashN, KaurJ. Reversal of hypermethylation and reactivation of the RARbeta2 gene by natural compounds in cervical cancer cell lines. Folia Biol (Krakow). 2010;56(5):195–200.
   Web of Science ®Google Scholar
• NakmareongS, KukongviriyapanU, PakdeechoteP, et al. Antioxidant and vascular protective effects of curcumin and tetrahydrocurcumin in rats with L-NAME-induced hypertension. Naunyn-Schmiedeberg’s Arch Pharmacol. 2011;383(5):519–529. doi:10.1007/s00210-011-0624-z21448566
   PubMedGoogle Scholar
• SunD, ZhuangX, XiangX, et al. A novel nanoparticle drug delivery system: the anti-inflammatory activity of curcumin is enhanced when encapsulated in exosomes. Mol Ther. 2010;18(9):1606–1614. doi:10.1038/mt.2010.10520571541
   PubMed Web of Science ®Google Scholar
• SalemiM, MohammadiS, GhavamzadehA, NikbakhtM. Anti-vascular endothelial growth factor targeting by curcumin and thalidomide in acute myeloid leukemia cells. Asian Pac J Cancer Prev. 2017;18(11):3055. doi:10.22034/APJCP.2017.18.1.2329172279
   PubMedGoogle Scholar
• ShehzadA, LeeJ, LeeYS. Curcumin in various cancers. Biofactors. 2013;39(1):56–68. doi:10.1002/biof.106823303705
   PubMed Web of Science ®Google Scholar
• ZoratF, ShettyV, DuttD, et al. The clinical and biological effects of thalidomide in patients with myelodysplastic syndromes. Br J Haematol. 2001;115(4):881–894. doi:10.1046/j.1365-2141.2001.03204.x11843822
   PubMed Web of Science ®Google Scholar
• InvernizziR, TravaglinoE, De AmiciM, et al. Thalidomide treatment reduces apoptosis levels in bone marrow cells from patients with myelodysplastic syndromes. Leuk Res. 2005;29(6):641–647. doi:10.1016/j.leukres.2004.11.00815863203
   PubMed Web of Science ®Google Scholar
• AdèsL, FenauxP. Immunomodulating drugs in myelodysplastic syndromes. ASH Educ Program Book. 2011;2011(1):556–560.
   Google Scholar
• Mohammadi KianM, MohammadiS, TavallaeiM, et al. Inhibitory effects of arsenic trioxide and thalidomide on angiogenesis and vascular endothelial growth factor expression in leukemia cells. Asian Pac J Cancer Prev. 2018;19(4):1127–1134. doi:10.22034/APJCP.2018.19.4.112729699374
   PubMedGoogle Scholar
• DöhnerH, WeisdorfDJ, BloomfieldCD. Acute myeloid leukemia. N Engl J Med. 2015;373(12):1136–1152. doi:10.1056/NEJMra140618426376137
   PubMed Web of Science ®Google Scholar
• WangZ, ZhangY, BanerjeeS, LiY, SarkarFH. Retracted: notch‐1 down‐regulation by curcumin is associated with the inhibition of cell growth and the induction of apoptosis in pancreatic cancer cells. Cancer. 2006;106(11):2503–2513. doi:10.1002/cncr.v106:1116628653
   PubMed Web of Science ®Google Scholar
• YuS, ShenG, KhorTO, KimJ-H, KongA-NT. Curcumin inhibits Akt/mammalian target of rapamycin signaling through protein phosphatase-dependent mechanism. Mol Cancer Ther. 2008;7(9):2609–2620. doi:10.1158/1535-7163.MCT-07-240018790744
   PubMed Web of Science ®Google Scholar
• HossainD, BhattacharyyaS, DasT, SaG. Curcumin: the multi-targeted therapy for cancer regression. Front Biosci (Schol Ed). 2011;4:335–355.
   Google Scholar
• GhoshAK, KayNE, SecretoCR, ShanafeltTD. Curcumin inhibits pro-survival pathways in CLL B-cells and has the potential to overcome stromal protection of CLL B-cells in combination with EGCG. Clin Cancer Res. 2009;15(4):1250. doi:10.1158/1078-0432.CCR-08-151119228728
   PubMed Web of Science ®Google Scholar
• KomorowskiJ, JerczyńskaH, SiejkaA, et al. Effect of thalidomide affecting VEGF secretion, cell migration, adhesion and capillary tube formation of human endothelial EA. hy 926 cells. Life Sci. 2006;78(22):2558–2563. doi:10.1016/j.lfs.2005.10.01616310808
   PubMed Web of Science ®Google Scholar
• RaoJ, XuD-R, ZhengF-M, et al. Curcumin reduces expression of Bcl-2, leading to apoptosis in daunorubicin-insensitive CD34+ acute myeloid leukemia cell lines and primary sorted CD34+ acute myeloid leukemia cells. J Transl Med. 2011;9(1):71. doi:10.1186/1479-5876-9-7121595920
   PubMed Web of Science ®Google Scholar
• GiannopoulosK, DmoszynskaA, KowalM, et al. Thalidomide exerts distinct molecular antileukemic effects and combined thalidomide/fludarabine therapy is clinically effective in high-risk chronic lymphocytic leukemia. Leukemia. 2009;23(10):1771–1778. doi:10.1038/leu.2009.9819440214
   PubMed Web of Science ®Google Scholar
• SungB, KunnumakkaraAB, SethiG, AnandP, GuhaS, AggarwalBB. Curcumin circumvents chemoresistance in vitro and potentiates the effect of thalidomide and bortezomib against human multiple myeloma in nude mice model. Mol Cancer Ther. 2009;8(4):959–970. doi:10.1158/1535-7163.MCT-08-090519372569
   PubMed Web of Science ®Google Scholar
• ZhuangL, LeeCS, ScolyerRA, et al. Mcl-1, Bcl-XL and Stat3 expression are associated with progression of melanoma whereas Bcl-2, AP-2 and MITF levels decrease during progression of melanoma. Mod Pathol. 2007;20(4):416–426. doi:10.1038/modpathol.380075017384650
   PubMed Web of Science ®Google Scholar
• MackenzieGG, QueisserN, WolfsonML, FragaCG, AdamoAM, OteizaPI. Curcumin induces cell‐arrest and apoptosis in association with the inhibition of constitutively active NF‐κB and STAT3 pathways in Hodgkin’s lymphoma cells. Int J Cancer. 2008;123(1):56–65. doi:10.1002/(ISSN)1097-021518386790
   PubMed Web of Science ®Google Scholar
• Han-S-S, ChungS-T, RobertsonDA, RanjanD, BondadaS. Curcumin causes the growth arrest and apoptosis of B cell lymphoma by downregulation of egr-1, c-myc, bcl-X L, NF-κB, and p53. Clin Immunol. 1999;93(2):152–161. doi:10.1006/clim.1999.476910527691
   PubMed Web of Science ®Google Scholar
• WooJ-H, KimY-H, ChoiY-J, et al. Molecular mechanisms of curcumin-induced cytotoxicity: induction of apoptosis through generation of reactive oxygen species, down-regulation of Bcl-XL and IAP, the release of cytochrome c and inhibition of Akt. Carcinogenesis. 2003;24(7):1199–1208. doi:10.1093/carcin/bgg08212807727
   PubMed Web of Science ®Google Scholar